Commentary on the NIH Consensus Development Statement(1) from the Meeting on November 17-19, 1997 Effective Medical Treatment of Heroin Addiction

The National Alliance of Methadone Advocates supports the NIH Consensus
Statement on Effective Treatment of Heroin Addiction that was facilitated by the
National Institute on Drug Abuse and the National Institute of Health.

The imprecate of this special statement should be understood in order to
realize the impact that it can have on methadone maintenance treatment. The
Consensus Statements are prepared by a special committee who are comprised of
individuals who are typically professionals from the disciplines involved in the
issue (i.e. doctors, lawyers, etc.) but they have no connections to the field
being examined. In this respect their conclusions are independent and thus
greater influence. The prepared statement is based on the (1) presentations from
panels consisting of professionals working in the field and relevant areas; (2)
questions and statements from conference attendees during open discussion
periods that are part of the public session; and (3) closed deliberations by The
Committee. Thus the statement is an independent report of the consensus panel
and is not a policy statement of the NIH or the Federal Government.

A Summary of the Recommendations are:

  1. Strong leadership is necessary in educating the public that addiction is
    not self inflicted but is a medical disorder that includes a spectrum of
    brain and medical conditions that can be effectively treated with benefits
    to society.

  2. Society needs to make a commitment to offer effective treatment for heroin
    addiction for all who need it.

  3. Opiate-addicted persons under legal supervision need to have access to
    methadone maintenance treatment.

  4. The training of physicians and other health care professionals need
    improvement regarding the diagnosis and treatment of opiate addiction.

  5. The unwarranted over regulation of methadone maintenance treatment and all
    opiate agonist treatment programs needs to be reduced.

  6. Funding for methadone maintenance treatment needs to be increased and
    required as a benefit for public and private insurance programs equivalent
    to the coverage for all medical and mental disorders.

  7. Chemically dependent pregnant women need to receive special consideration
    and methadone maintenance treatment must be culturally sensitive to enhance
    favorable outcomes for participating African American and Hispanic persons.

  8. Patients, underrepresented minorities, and consumers should be included in
    bodies charged with policy development guiding opiate addiction treatment.

  9. Methadone maintenance treatment needs to be expanded within States and
    regions where programs where it is currently unavailable.

Summary

The Consensus Committee in their full statement emphasized the rigorous
scientific studies that methadone maintenance had undergone over the past 30
years that demonstrate its effectiveness in significantly lowering illicit
opiate drug use, reducing illness and death from illicit opiate drug use,
reducing crime, and by enhancing social productivity. And that in order for
methadone maintenance treatment to receive adequate funding and it’s expansion
be supported it will be necessary to undertake a campaign to educate
politicians, policy makers and society that opiate addiction is a medical
disorder and methadone is effective in treating it.

To replace the regulations The Committee recommended alternatives such as
physician accreditation and certification and to improve education that
physicians, nurses and other health professionals receive. While reducing
regulations will help to promote expansion of methadone maintenance treatment
increased funding is necessary to ensure expansion in all states including those
that do not currently provide it. The Committee strongly recommended that
legislators and regulators recognize the cost effectiveness of methadone
maintenance treatment and that benefits for treatment be part of public and
private insurance programs.

Bodies charged with policy The Committee urged should be include
misrepresented minorities and patients. The Committee stressed that methadone
treatment must be culturally sensitive and that risk groups, such as pregnant
women should be targeted.

What Can Advocates Do?

It is now important for us to ensure that the conclusion of this Consensus
Statement become known by politicians and policy makers. Patients and the family
members of patients should write to their representatives and tell them that
methadone maintenance treatment does work and most important that it saves ad
restores lives. Do not stop at the federal and national level continue writing
and talking with state and local politicians and policy makers. Because
methadone maintenance treatment has been politicized it is at that level that
must first be education. This Consensus Statements give us the chance to promote
and influence the medicalization of methadone maintenance treatment.




1. Effective Medical
Treatment of Heroin Addiction
. NIH Consensus Statement 1997 November
17-19;15(6). Available from the National
Clearinghouse for Alcohol and Drug Information
NCADI


Similar Posts

  • NAMA Affiliate Page

    Admin 04/06/2023

    NAMA WebsiteMethadone.orgPages to Remember State Methadone Authorities Education Series New Federal Regulations Final Rule Federal and State Regulations & Resources Don’t miss an important phone call ever again! Use Call Wave to tell you when the phone is ringing.and who is on the other end and if you should pick it up. If it is…

  • The Ombudsman

    Admin 10/06/2021

    Issue Number 3/4, Spring/Summer 1995 Contents Let’s Stop The Insanity by Anthony Scro Presidential Notes by Stan Novick The Editor’s Letter Methaphobia: Us and Them by Ira Sobel Stigma: The Invisible Barrier by Herman Joseph and Joycelyn Woods Methadone Treatment in New York by M. Grenga and H. S. Nelson Methaphobia Crossword Puzzle The Impact…

  • |

    Internet Resources

    Admin 05/29/2021

    Treatment Facility Locator Buprenorphine Physician Locator Maintenance Assistance Point (Europe) Indro’s Coordinating and Information Resource Center for International Travel Traveler’s Health Kit Office of National Drug Control Policy Center For Substance Abuse Treatment CSAT Patient Support & Community Education Project Program Version (PDF Format) National Clearinghouse Opioid Drugs in Maintenance and Detoxification Treatment of Opiate…

  • The Media Newspapers

    Admin 06/15/2022

    Blame Does Not Benefit Society LTE [email protected] Ref: Myles F. Jacques 12/4/2002 Choice has consequences Editor: In responding to Jerome Kukaitis’ Nov. 27 letter regarding Mayor Wiercinski’s comment that “Hell would freeze over first before a methadone clinic opens in Dickson City” Mr. Jacques misses several vital points. 1. Addiction is a medical condition. It…

  • AMTA Conference Comittee

    Admin 06/15/2023

    Conference 2000 American Methadone Treatment Association April 9-12, 2000 San Francisco Committee Chair John Finger Committee Members Assistant to the Chair, Michael Garrett Co-chair, Alice Diorio Committee James DePasquale Becky Duarte Barbara Finger Carlos Franco Greg Keller Howard Lotsof Judith Ostergard Carmen Pearman Diane Seaman Joycelyn Woods NAMA Events and Activities Exhibition Booth Booth Manager:…

  • Favorite Links

    Admin 10/26/2022

    Links Favorite Links National Alliance of Methadone Advocates Rokki’s Methadone List Bitch and Gripe Methadone Espanol Bulletin Board TexNAMA New Zealand Methadone Advocates Pagina del Gruppo SIMS (NAMA Materials in Italian) Brugerforeningen (NAMA Materials in Danish) Addiction Treatment Forum The Ibogaine Dossier American Society of Addiction Medicine Center for Substance Abuse Treatment CSAT Treatment Facility…